Intersect ENT announces FDA approval of SINUVA™ sinus implant
Intersect ENT announced it has received approval from the FDA for the SINUVA™ (mometasone furoate) Sinus Implant, a new targeted approach to treating recurrent nasal polyp disease in patients who have had previous ethmoid sinus surgery. December 11, 2017